Medicine
Eurax 10% cream
Eurax 10% cream is a prescription medicine containing Crotamiton for topical use, marketed by Journey Medical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, 20˚C - 25˚C (68˚F - 77˚F), Excursions permitted…
Key facts
- Active ingredient (INN)
- Crotamiton
- Brand
- Eurax
- Strength
- 10%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- Journey Medical
- Manufacturer
- Journey Medical
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, 20˚C - 25˚C (68˚F - 77˚F), Excursions permitted: 15˚C - 30˚C (59˚F - 86˚F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 March 2026
- Identifiers
- RxCUI 207864, 309552DailyMed set ID 99c826aa-c7dd-4e60-be9c-e9c151033d13NDC 69489-311Application NDA006927
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 60 g in 1 tube | 69489-311-60 | Journey Medical | 16 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 July 1949 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Crotamiton
Clinical summary
Crotamiton is a prescription medicine. It is available as lotion and cream for topical use. MedsAcross supplies Crotamiton for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CrotamitonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Eurax prescribing information (Journey Medical) · U.S. National Library of Medicine, DailyMed
Need Eurax 10% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.